296 related articles for article (PubMed ID: 16358615)
41. Prophylactic mastectomy.
Zakaria S; Degnim AC
Surg Clin North Am; 2007 Apr; 87(2):317-31, viii. PubMed ID: 17498529
[TBL] [Abstract][Full Text] [Related]
42. Bilateral prophylactic mastectomy: issues and concerns.
Stefanek ME
J Natl Cancer Inst Monogr; 1995; (17):37-42. PubMed ID: 8573451
[TBL] [Abstract][Full Text] [Related]
43. Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies.
Francken AB; Schouten PC; Bleiker EM; Linn SC; Rutgers EJ
Breast; 2013 Oct; 22(5):561-8. PubMed ID: 23972475
[TBL] [Abstract][Full Text] [Related]
44. Contralateral recurrence and prognostic factors in familial non-BRCA1/2-associated breast cancer.
Tilanus-Linthorst MM; Alves C; Seynaeve C; Menke-Pluymers MB; Eggermont AM; Brekelmans CT
Br J Surg; 2006 Aug; 93(8):961-8. PubMed ID: 16758466
[TBL] [Abstract][Full Text] [Related]
45. The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy.
Golshan M; Miron A; Nixon AJ; Garber JE; Cash EP; Iglehart JD; Harris JR; Wong JS
Am J Surg; 2006 Jul; 192(1):58-62. PubMed ID: 16769276
[TBL] [Abstract][Full Text] [Related]
46. Prophylactic bilateral mastectomy: patterns of practice.
Metcalfe KA; Goel V; Lickley L; Semple J; Narod SA
Cancer; 2002 Jul; 95(2):236-42. PubMed ID: 12124821
[TBL] [Abstract][Full Text] [Related]
47. Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.
Kauff ND; Barakat RR
J Clin Oncol; 2007 Jul; 25(20):2921-7. PubMed ID: 17617523
[TBL] [Abstract][Full Text] [Related]
48. Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation.
Metcalfe KA; Poll A; O'Connor A; Gershman S; Armel S; Finch A; Demsky R; Rosen B; Narod SA
Clin Genet; 2007 Sep; 72(3):208-17. PubMed ID: 17718858
[TBL] [Abstract][Full Text] [Related]
49. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
[TBL] [Abstract][Full Text] [Related]
50. A survey of preventive measures among BRCA1 mutation carriers from Poland.
Gronwald J; Byrski T; Huzarski T; Cybulski C; Stawicka M; Szwiec M; Debniak T; Tulman A; Sun P; Oszurek O; Lubinski J; Narod SA
Clin Genet; 2007 Feb; 71(2):153-7. PubMed ID: 17250664
[TBL] [Abstract][Full Text] [Related]
51. Breast cancer treatment in mutation carriers: surgical treatment.
Biglia N; D'Alonzo M; Sgro LG; Tomasi Cont N; Bounous V; Robba E
Minerva Ginecol; 2016 Oct; 68(5):548-56. PubMed ID: 26822896
[TBL] [Abstract][Full Text] [Related]
52. Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers.
van Sprundel TC; Schmidt MK; Rookus MA; Brohet R; van Asperen CJ; Rutgers EJ; Van't Veer LJ; Tollenaar RA
Br J Cancer; 2005 Aug; 93(3):287-92. PubMed ID: 16052221
[TBL] [Abstract][Full Text] [Related]
53. Invasive breast cancer following bilateral subcutaneous mastectomy in a BRCA2 mutation carrier: a case report and review of the literature.
Kasprzak L; Mesurolle B; Tremblay F; Galvez M; Halwani F; Foulkes WD
World J Surg Oncol; 2005 Aug; 3():52. PubMed ID: 16079000
[TBL] [Abstract][Full Text] [Related]
54. [Prophylactic mastectomy in women at high risk for breast cancer: indications and options].
Scheufler O; Fritschen Uv
Handchir Mikrochir Plast Chir; 2008 Aug; 40(4):239-47. PubMed ID: 18716986
[TBL] [Abstract][Full Text] [Related]
55. Post-mastectomy surveillance of BRCA1/BRCA2 mutation carriers: Outcomes from a specialized clinic for high-risk breast cancer patients.
Kanana N; Ben David MA; Nissan N; Yagil Y; Shalmon A; Halshtok O; Gotlieb M; Faermann R; Klang E; Samoocha D; Yassin M; Davidson T; Zippel D; Madorsky Feldman D; Friedman E; Kaidar-Person O; Sklair Levy M
Breast J; 2021 May; 27(5):441-447. PubMed ID: 33576117
[TBL] [Abstract][Full Text] [Related]
56. [Genetic changes in breast cancer - an overview].
Dimitrov G; Iovchev I; Nikolov S
Khirurgiia (Sofiia); 2000; 56(5-6):60-2. PubMed ID: 11692938
[TBL] [Abstract][Full Text] [Related]
57. The expected benefit of preventive mastectomy on breast cancer incidence and mortality in BRCA mutation carriers, by age at mastectomy.
Giannakeas V; Narod SA
Breast Cancer Res Treat; 2018 Jan; 167(1):263-267. PubMed ID: 28914396
[TBL] [Abstract][Full Text] [Related]
58. International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom.
Den Heijer M; van Asperen CJ; Harris H; Nippert I; Schmidtke J; Bouhnik AD; Julian-Reynier C; Evans DG; Tibben A
Eur J Cancer; 2013 Sep; 49(13):2798-805. PubMed ID: 23692813
[TBL] [Abstract][Full Text] [Related]
59. Risk-reducing mastectomy for BRCA gene mutation carriers.
Euhus DM
Ann Surg Oncol; 2015 Sep; 22(9):2807-9. PubMed ID: 25821000
[No Abstract] [Full Text] [Related]
60. The Preventive Intervention of Hereditary Breast Cancer.
Cao A; Huang L; Shao Z
Adv Exp Med Biol; 2017; 1026():41-57. PubMed ID: 29282679
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]